Westover Capital Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-33,643
Closed -$944K 176
2023
Q3
$944K Sell
33,643
-1,602
-5% -$55K 0.34% 71
2023
Q2
$1.3M Sell
35,245
-2,213
-6% -$67.5K 0.45% 56
2023
Q1
$1.12M Sell
37,458
-960
-2% -$31.6K 0.42% 63
2022
Q4
$1.18M Sell
38,418
-26,433
-41% -$793K 0.46% 60
2022
Q3
$1.6M Buy
64,851
+44,128
+213% +$1.46M 0.61% 53
2022
Q2
$664K Buy
+20,723
New +$762K 0.24% 83
2018
Q4
Sell
-21,837
Closed -$861K 116
2018
Q3
$861K Sell
21,837
-5,954
-21% -$261K 0.44% 64
2018
Q2
$1.23M Buy
+27,791
New +$1.38M 0.66% 49

Other funds holding CC

Westover Capital Advisors's CC Position: Q4 2023 in Review

Westover Capital Advisors sold out of Chemours (CC) in Q4 2023, closing a stake of 33,643 shares — an estimated $944K sold.

Westover Capital Advisors first reported a position in CC in Q2 2018 and held it in 8 quarters. The position peaked at $1.6M in Q3 2022. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • Westover Capital Advisors reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • Westover Capital Advisors sold 33,643 Chemours shares in Q4 2023, an estimated $944K.
  • Westover Capital Advisors first reported a position in Chemours in Q2 2018 and held it in 8 quarters.
  • Westover Capital Advisors's Chemours position peaked at $1.6M in Q3 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Westover Capital Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.